Aprogen Biologics Inc. (KRX: 003060)

Aprogen Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 15, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	140,672	190,684	200,481	360,706	524,120	327,440
Market Cap Growth	-73.90%	-4.89%	-44.42%	-31.18%	60.07%	27.27%
Enterprise Value	186,670	383,113	209,570	302,520	379,267	327,460
Last Close Price	712.00	2203.94	3822.70	6877.82	9993.74	9070.88
PE Ratio	-	-	12.33	34.39	28.55	-
PS Ratio	0.64	2.18	3.08	6.39	9.83	6.43
PB Ratio	0.24	0.52	0.39	0.60	0.88	0.94
P/TBV Ratio	0.17	0.53	0.48	0.71	1.04	1.35
P/FCF Ratio	-	-	8.20	-	73.70	-
P/OCF Ratio	-	-	7.79	-	64.80	458.77
EV/Sales Ratio	2.54	4.39	3.21	5.36	7.11	6.43
EV/EBITDA Ratio	6.73	-	-	-	445.50	-
EV/FCF Ratio	-4.13	-	8.57	-	53.33	-
Debt / Equity Ratio	0.42	0.49	0.26	0.00	0.00	0.01
Debt / EBITDA Ratio	-	-	-	-	3.49	-
Debt / FCF Ratio	-	-	5.51	-	0.42	-
Asset Turnover	0.11	0.14	0.10	0.09	0.11	0.17
Inventory Turnover	1.43	1.98	1.26	3.09	3.25	3.60
Quick Ratio	0.25	0.17	0.75	15.45	25.69	10.04
Current Ratio	0.71	0.54	1.49	37.41	38.79	18.09
Return on Equity (ROE)	-29.11%	-26.24%	2.46%	1.53%	4.00%	-1.39%
Return on Assets (ROA)	-7.51%	-6.94%	-0.40%	-0.40%	-0.14%	-0.41%
Return on Capital (ROIC)	-8.15%	-7.40%	-0.42%	-0.41%	-0.14%	-0.45%
Earnings Yield	-277.75%	-62.02%	6.30%	2.25%	2.15%	-2.54%
FCF Yield	-32.15%	-32.38%	12.19%	-1.95%	1.36%	-0.43%
Buyback Yield / Dilution	-30.86%	-56.07%	-1.42%	-25.52%	-94.17%	-66.31%
Total Shareholder Return	-30.86%	-56.07%	-1.42%	-25.52%	-94.17%	-66.31%

Source: S&P Capital IQ. Standard template. Financial Sources.